{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T16:22:08Z","timestamp":1784132528583,"version":"3.55.0"},"reference-count":152,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["NIHR128996"],"award-info":[{"award-number":["NIHR128996"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"<jats:sec id=\"abs1-1\"><jats:title>Background<\/jats:title>\n<jats:p>Selected patients with advanced heart failure ineligible for heart transplantation could benefit from left ventricular assist device therapy as \u2018destination therapy\u2019. There is evidence of the efficacy of destination therapy; however, it is not currently commissioned within the United Kingdom National Health Service due to the lack of economic evidence.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-2\"><jats:title>Objective<\/jats:title>\n<jats:p>What is the clinical and cost-effectiveness of a left ventricular assist device compared to medical management for patients with advanced heart failure ineligible for heart transplantation (destination therapy)?<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-3\"><jats:title>Methods<\/jats:title>\n<jats:p>A systematic review of evidence on the clinical and cost-effectiveness of left ventricular assist devices as destination therapy was undertaken including, where feasible, a network meta-analysis to provide an indirect estimate of the relative effectiveness of currently available left ventricular assist devices compared to medical management. For the systematic reviews, data sources searched (up to 11 January 2022) were Cochrane CENTRAL, MEDLINE and EMBASE via Ovid for primary studies, and Epistemonikos and Cochrane Database of Systematic Reviews for relevant systematic reviews. Trial registers were also searched, along with data and reports from intervention-specific registries. Economic studies were identified in EconLit, CEA registry and the NHS Economic Evaluation Database (NHS EED). The searches were supplemented by checking reference lists of included studies. An economic model (Markov) was developed to estimate the cost-effectiveness of left ventricular assist devices compared to medical management from the United Kingdom National Health Service\/personal social service perspective. Deterministic and probabilistic sensitivity analyses were conducted to explore uncertainties. Where possible, all analyses focused on the only currently available left ventricular assist device (HeartMate 3<jats:sup>TM<\/jats:sup>, Abbott, Chicago, IL, USA) in the United Kingdom.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-4\"><jats:title>Results<\/jats:title>\n<jats:p>The clinical effectiveness review included 134 studies (240 articles). There were no studies directly comparing HeartMate 3 and medical management (a randomised trial is ongoing). The currently available left ventricular assist device improves patient survival and reduces stroke rates and complications compared to earlier devices and relative to medical management. For example, survival at 24 months is 77% with the HeartMate 3 device compared to 59% with the HeartMate II (MOMENTUM 3 trial). An indirect comparison demonstrated a reduction in mortality compared to medical management [relative risk of death 0.25 (95% confidence interval 0.13 to 0.47); 24 months; this study].<\/jats:p>\n<jats:p>The cost-effectiveness review included 5 cost analyses and 14 economic evaluations covering different generations of devices and with different perspectives. The reported incremental costs per quality-adjusted life-year gained compared to medical management were lower for later generations of devices [as low as \u00a346,207 (2019 prices; United Kingdom perspective; time horizon at least 5 years)].<\/jats:p>\n<jats:p>The economic evaluation used different approaches to obtain the relative effects of current left ventricular assist devices compared to medical management from the United Kingdom National Health Service\/personal social service perspective. All gave similar incremental cost-effectiveness ratios of \u00a353,496\u201358,244 per quality-adjusted life-year gained \u2013\u00a0lifetime horizon. Model outputs were sensitive to parameter estimates relating to medical management. The findings did not materially differ on exploratory subgroup analyses based on the severity of heart failure.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-5\"><jats:title>Limitations<\/jats:title>\n<jats:p>There was no direct evidence comparing the clinical effectiveness of HeartMate 3 to medical management. Indirect comparisons made were based on limited data from heterogeneous studies regarding the severity of heart failure (Interagency Registry for Mechanically Assisted Circulatory Support score distribution) and possible for survival only. Furthermore, the cost of medical management of advanced heart failure in the United Kingdom is not clear.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-6\"><jats:title>Conclusions<\/jats:title>\n<jats:p>Using cost-effectiveness criteria applied in the United Kingdom, left ventricular assist devices compared to medical management for patients with advanced heart failure ineligible for heart transplant may not be cost-effective. When available, data from the ongoing evaluation of HeartMate 3 compared to medical management can be used to update cost-effectiveness estimates. An audit of the costs of medical management in the United Kingdom is required to further decrease uncertainty in the economic evaluation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-7\"><jats:title>Study registration<\/jats:title>\n<jats:p>This study is registered as PROSPERO CRD42020158987.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"abs1-8\"><jats:title>Funding<\/jats:title>\n<jats:p>This award was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme\u00a0(NIHR award ref: NIHR128996) and is published in full in <jats:italic>Health Technology Assessment<\/jats:italic>; Vol. 28, No. 38. See the NIHR Funding and Awards website for further award information.<\/jats:p>\n<\/jats:sec>","DOI":"10.3310\/mlfa4009","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T13:22:42Z","timestamp":1724764962000},"page":"1-237","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for advanced heart failure: systematic review and economic evaluation"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6329-0779","authenticated-orcid":true,"given":"Sophie","family":"Beese","sequence":"first","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4143-3852","authenticated-orcid":true,"given":"Tuba S","family":"Av\u015far","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7352-3027","authenticated-orcid":true,"given":"Malcolm","family":"Price","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2465-305X","authenticated-orcid":true,"given":"David","family":"Quinn","sequence":"additional","affiliation":[{"name":"Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6569-1805","authenticated-orcid":true,"given":"Hoong S","family":"Lim","sequence":"additional","affiliation":[{"name":"Cardiology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2591-6918","authenticated-orcid":true,"given":"Janine","family":"Dretzke","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8133-7021","authenticated-orcid":true,"given":"Chidubem O","family":"Ogwulu","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0519-3724","authenticated-orcid":true,"given":"Pelham","family":"Barton","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8492-0020","authenticated-orcid":true,"given":"Louise","family":"Jackson","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4163-4080","authenticated-orcid":true,"given":"David","family":"Moore","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Research, University of Birmingham, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2024,8]]},"reference":[{"key":"key2024082718460900_ref1-bib1","first-page":"48","article-title":"Chronic heart failure: causes, pathophysiology, prognosis, clinical manifestations, investigations","author":"Poole-Wilson","year":"1989","journal-title":"Dis Heart"},{"key":"key2024082718460900_ref2-bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta9450","article-title":"The clinical and cost-effectiveness of left ventricular assist devices for end-stage heart failures: a systematic review and economic evaluation","volume":"9","author":"Clegg","year":"2005","journal-title":"Health Technol Assess"},{"key":"key2024082718460900_ref3-bib3","volume-title":"Chronic Heart Failure in Adults: Diagnosis and Management","author":"National Institute for Health and Care Excellence","year":"2018"},{"key":"key2024082718460900_ref4-bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12955-014-0123-2","article-title":"Change in health status in long-term conditions over a one year period: a cohort survey using patient-reported outcome measures","volume":"12","author":"Peters","year":"2014","journal-title":"Health Qual Life Outcomes"},{"key":"key2024082718460900_ref5-bib5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cardfail.2008.09.006","article-title":"Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls","volume":"15","author":"Lesman-Leegte","year":"2009","journal-title":"J Card Fail"},{"key":"key2024082718460900_ref6-bib6","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/j.1875-9114.1998.tb03155.x","article-title":"Effects of ACE inhibitor therapy on quality of life in patients with heart failure","volume":"18","author":"Wolfel","year":"1998","journal-title":"Pharmacotherapy"},{"key":"key2024082718460900_ref7-bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0735-1097(02)01932-0","article-title":"Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study","volume":"40","author":"Linde","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key2024082718460900_ref8-bib8","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/acm.2005.11.465","article-title":"Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study","volume":"11","author":"Curiati","year":"2005","journal-title":"J Altern Complement Med"},{"key":"key2024082718460900_ref9-bib9","article-title":"Exercise-based cardiac rehabilitation for adults with heart failure","volume":"1","author":"Long","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"key2024082718460900_ref10-bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/CIRCULATIONAHA.111.040279","article-title":"Quality of life and left ventricular assist device support","volume":"126","author":"MacIver","year":"2012","journal-title":"Circulation"},{"key":"key2024082718460900_ref11-bib11","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/CIRCULATIONAHA.106.670901","article-title":"Identifying heart failure patients at high risk for near-term cardiovascular events with serial health status assessments","volume":"115","author":"Kosiborod","year":"2007","journal-title":"Circulation"},{"key":"key2024082718460900_ref12-bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/eurjhf\/hfs148","article-title":"Quality of life and survival in patients with heart failure","volume":"15","author":"Hoekstra","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"key2024082718460900_ref13-bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/CIRCHEARTFAILURE.112.000291","article-title":"Physical health status measures predict all-cause mortality in patients with heart failure","volume":"6","author":"Chamberlain","year":"2013","journal-title":"Circ Heart Fail"},{"key":"key2024082718460900_ref14-bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11136-013-0468-8","article-title":"Should patients perception of health status be integrated in the prognostic assessment of heart failure patients? A prospective study","volume":"23","author":"Di Giulio","year":"2014","journal-title":"Qual Life Res"},{"key":"key2024082718460900_ref15-bib15","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/JCN.0000000000000248","article-title":"Health-related quality of life, functional status, and cardiac event-free survival in patients with heart failure","volume":"31","author":"Wu","year":"2016","journal-title":"J Cardiovasc Nurs"},{"key":"key2024082718460900_ref16-bib16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jacc.2012.12.038","article-title":"Heart failure\u2013associated hospitalizations in the United States","volume":"61","author":"Blecker","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key2024082718460900_ref17-bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"key2024082718460900_ref18-bib18","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"key2024082718460900_ref19-bib19","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"key2024082718460900_ref20-bib20","volume-title":"National Audit of Cardiac Rehabilitation (NACR) Quality and Outcomes Report","author":"British Heart Foundation","year":"2020"},{"key":"key2024082718460900_ref21-bib21","doi-asserted-by":"crossref","first-page":"D50","DOI":"10.1093\/ehjsupp\/4.suppl_D.D50","article-title":"The burden of heart failure","volume":"4","author":"McMurray","year":"2002","journal-title":"Eur Heart J Suppl"},{"key":"key2024082718460900_ref22-bib22","unstructured":"National Institute for Cardiovascular Outcomes Research. National Heart Failure Audit 2020\/21 Summary Report. Healthcare Quality Improvement Partnership (HQIP): London; 2021."},{"key":"key2024082718460900_ref23-bib23","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1002\/ejhf.2143","article-title":"The Heart Failure Association Atlas: heart failure epidemiology and management statistics 2019","volume":"23","author":"Seferovi\u0107","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"key2024082718460900_ref24-bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jchf.2021.05.009","article-title":"Advanced heart failure epidemiology and outcomes: a population-based study","volume":"9","author":"Dunlay","year":"2021","journal-title":"JACC Heart Fail"},{"key":"key2024082718460900_ref25-bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1053\/euhj.1998.1280","article-title":"Incidence and aetiology of heart failure; a population-based study","volume":"20","author":"Cowie","year":"1999","journal-title":"Eur Heart J"},{"key":"key2024082718460900_ref26-bib26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7326\/0003-4819-155-4-201108160-00009","article-title":"Management of chronic heart failure in adults: synopsis of the National Institute for Health and clinical excellence guideline","volume":"155","author":"Mant","year":"2011","journal-title":"Ann Intern Med"},{"key":"key2024082718460900_ref27-bib27","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ejheart.2007.04.003","article-title":"Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology","volume":"9","author":"Metra","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"key2024082718460900_ref28-bib28","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCOUTCOMES.110.957225","article-title":"Lifetime costs of medical care after heart failure diagnosis","volume":"4","author":"Dunlay","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key2024082718460900_ref29-bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12872-018-0815-3","article-title":"Cost-of-illness studies in heart failure: a systematic review 2004\u20132016","volume":"18","author":"Lesyuk","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"key2024082718460900_ref30-bib30","unstructured":"National Health Service Blood and Transplant. Annual Report on Cardiothoracic Organ Transplantation. 2021. URL: https:\/\/nhsbtdbe.blob.core.windows.net\/umbraco-assets-corp\/25266\/nhsbt-annual-report-on-cardiothoracic-organ-transplantation-202021.pdf (accessed 28 August 2023)."},{"key":"key2024082718460900_ref31-bib31","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.athoracsur.2020.12.038","article-title":"The society of thoracic surgeons Intermacs 2020 annual report","volume":"111","author":"Molina","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"key2024082718460900_ref32-bib32","volume-title":"FDA Alerts Health Care Providers to Stop New Implants of Certain Ventricular Assist Device System","author":"Medtronic Mechanical Circulatory Support","year":"2021"},{"key":"key2024082718460900_ref33-bib33","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/ejhf.2275","article-title":"Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo\u2010controlled, non-inferiority ARIES HM3 trial","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"key2024082718460900_ref34-bib34","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cardfail.2016.10.015","article-title":"The physiology of continuous-flow left ventricular assist devices","volume":"23","author":"Lim","year":"2017","journal-title":"J Card Fail"},{"key":"key2024082718460900_ref35-bib35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.healun.2020.03.001","article-title":"Effect of aspirin dose on hemocompatibility-related outcomes with a magnetically levitated left ventricular assist device: an analysis from the MOMENTUM 3 study","volume":"39","author":"Saeed","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref36-bib36","doi-asserted-by":"crossref","first-page":"e006994","DOI":"10.1161\/CIRCHEARTFAILURE.120.006994","article-title":"Predicting the risk of right ventricular failure in patients undergoing left ventricular assist device implantation: a systematic review","volume":"13","author":"Frankfurter","year":"2020","journal-title":"Circ Heart Fail"},{"key":"key2024082718460900_ref37-bib37","doi-asserted-by":"crossref","first-page":"e003863","DOI":"10.1161\/CIRCHEARTFAILURE.117.003863","article-title":"Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation: incidence and risk factors from the Interagency Registry for Mechanically Assisted Circulatory Support","volume":"10","author":"Kiernan","year":"2017","journal-title":"Circ Heart Fail"},{"key":"key2024082718460900_ref38-bib38","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.jchf.2018.07.012","article-title":"Aortic insufficiency during contemporary left ventricular assist device support: analysis of the INTERMACS registry","volume":"6","author":"Truby","year":"2018","journal-title":"JACC Heart Fail"},{"key":"key2024082718460900_ref39-bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/MAT.0000000000000684","article-title":"Left ventricular assist device infections: a systematic review","volume":"64","author":"O\u2019Horo","year":"2018","journal-title":"ASAIO J"},{"key":"key2024082718460900_ref40-bib40","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"key2024082718460900_ref44-bib44","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"key2024082718460900_ref45-bib45","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S0895-4356(97)00049-8","article-title":"The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials","volume":"50","author":"Bucher","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"key2024082718460900_ref46-bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.athoracsur.2019.12.005","article-title":"The Society of Thoracic Surgeons Intermacs 2019 annual report: the changing landscape of devices and indications","volume":"109","author":"Teuteberg","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"key2024082718460900_ref47-bib47","volume-title":"Prospective Multi-center Randomized Study for Evaluating the EVAHEART\u00ae2 Left Ventricular Assist System","author":"NCT, Evaheart Inc","year":"2010"},{"key":"key2024082718460900_ref48-bib48","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/ejhf.1773","article-title":"Randomized trial of a left ventricular assist device as destination therapy versus guideline-directed medical therapy in patients with advanced heart failure. Rationale and design of the SWEdish evaluation of left Ventricular Assist Device (SweVAD) trial","volume":"22","author":"Karason","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"key2024082718460900_ref49-bib49","volume-title":"Swedish Evaluation of Left Ventricular Assist Device as Permanent Treatment in End-stage Heart Failure","author":"NCT","year":"2015"},{"key":"key2024082718460900_ref50-bib50","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.healun.2018.01.085","article-title":"Sustaining quality of life of the aged: heart transplant or mechanical support (SUSTAIN-IT): baseline findings","volume":"37","author":"Grady","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref53-bib53","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ejhf.1113","article-title":"Platelet activation is a preoperative risk factor for the development of thromboembolic complications in patients with continuous-flow left ventricular assist device","volume":"20","author":"Consolo","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"key2024082718460900_ref54-bib54","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N Engl J Med"},{"key":"key2024082718460900_ref55-bib55","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1056\/NEJMoa0909938","article-title":"Advanced heart failure treated with continuous-flow left ventricular assist device","volume":"361","author":"Slaughter","year":"2009","journal-title":"N Engl J Med"},{"key":"key2024082718460900_ref56-bib56","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N Engl J Med"},{"key":"key2024082718460900_ref57-bib57","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jchf.2018.05.012","article-title":"HVAD: the ENDURANCE supplemental trial","volume":"6","author":"Milano","year":"2018","journal-title":"JACC Heart Fail"},{"key":"key2024082718460900_ref58-bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamacardio.2019.5323","article-title":"Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the multicenter study of MagLev Technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3) randomized clinical trial","volume":"5","author":"Goldstein","year":"2019","journal-title":"JAMA Cardiol"},{"key":"key2024082718460900_ref59-bib59","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jchf.2017.06.014","article-title":"INTERMACS analysis of stroke during support with continuous-flow left ventricular assist devices: risk factors and outcomes","volume":"5","author":"Acharya","year":"2017","journal-title":"JACC Heart Fail"},{"key":"key2024082718460900_ref60-bib60","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cjca.2020.06.010","article-title":"The effect of age on outcomes after destination-therapy left ventricular assist device implantation: an analysis of the IMACS registry","volume":"37","author":"Aleksova","year":"2021","journal-title":"Can J Cardiol"},{"key":"key2024082718460900_ref61-bib61","doi-asserted-by":"crossref","first-page":"08","DOI":"10.1161\/CIRCHEARTFAILURE.115.002800","article-title":"Frequency of poor outcome (death or poor quality of life) after left ventricular assist device for destination therapy: results from the INTERMACS registry","volume":"9","author":"Arnold","year":"2016","journal-title":"Circ Heart Fail"},{"key":"key2024082718460900_ref62-bib62","doi-asserted-by":"crossref","first-page":"e004384","DOI":"10.1161\/CIRCHEARTFAILURE.117.004384","article-title":"Outcomes after continuous-flow left ventricular assist device implantation as destination therapy at transplant versus nontransplant centers","volume":"11","author":"Brinkley","year":"2018","journal-title":"Circ Heart Fail"},{"key":"key2024082718460900_ref63-bib63","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.1016\/j.healun.2016.01.414","article-title":"Destination therapy in a single uropean country insights from the ITAMACS registry","volume":"35","author":"Feltrin","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref64-bib64","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.healun.2019.02.004","article-title":"Third annual report from the ISHLT Mechanically Assisted Circulatory Support registry: a comparison of centrifugal and axial continuous-flow left ventricular assist devices","volume":"38","author":"Goldstein","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref65-bib65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2014.10.001","article-title":"Change in health-related quality of life from before to after destination therapy mechanical circulatory support is similar for older and younger patients: analyses from INTERMACS","volume":"34","author":"Grady","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref66-bib66","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/MAT.0000000000001228","article-title":"Defining optimal outcomes in patients with left ventricular assist devices","volume":"67","author":"Kanwar","year":"2021","journal-title":"ASAIO J"},{"key":"key2024082718460900_ref67-bib67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.healun.2016.01.002","article-title":"First annual IMACS report: a global International Society for Heart and Lung Transplantation Registry for Mechanical Circulatory Support","volume":"35","author":"Kirklin","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref68-bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.healun.2010.12.001","article-title":"Third INTERMACS annual report: the evolution of destination therapy in the United States","volume":"30","author":"Kirklin","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref69-bib69","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jtcvs.2012.05.044","article-title":"Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation?","volume":"144","author":"Kirklin","year":"2012","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key2024082718460900_ref70-bib70","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.healun.2018.01.1294","article-title":"Second annual report from the ISHLT Mechanically Assisted Circulatory Support Registry","volume":"37","author":"Kirklin","year":"2018","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref71-bib71","doi-asserted-by":"crossref","first-page":"S124","DOI":"10.1016\/j.healun.2019.01.292","article-title":"Does indication for LVAD at time of implant matter in younger patients?","volume":"38","author":"Lala","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref72-bib72","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/jamacardio.2020.0631","article-title":"Strategies of wait-listing for heart transplant vs durable mechanical circulatory support alone for patients with advanced heart failure","volume":"5","author":"Lala","year":"2020","journal-title":"JAMA Cardiol"},{"key":"key2024082718460900_ref73-bib73","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.athoracsur.2016.03.040","article-title":"Limited utility of tricuspid valve repair at the time of left ventricular assist device implantation","volume":"101","author":"Song","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"key2024082718460900_ref74-bib74","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.athoracsur.2021.04.045","article-title":"STS INTERMACS database: the key to conduct single-arm trials in advanced heart failure patients","volume":"113","author":"Symalla","year":"2022","journal-title":"Ann Thorac Surg"},{"key":"key2024082718460900_ref75-bib75","doi-asserted-by":"crossref","first-page":"S208","DOI":"10.1016\/j.healun.2020.01.826","article-title":"Health-related quality of life differs by pre-operative implant strategy from before through mid-term after surgery: findings from INTERMACS","volume":"39","author":"White-Williams","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref76-bib76","first-page":"S01","article-title":"Periprocedural outcome after left ventricular assist device implantation in septuagenarians","volume":"69","author":"Kalampokas","year":"2021"},{"key":"key2024082718460900_ref77-bib77","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.healun.2015.10.024","article-title":"Pump thrombosis in the Thoratec HeartMate II device: an update analysis of the INTERMACS registry","volume":"34","author":"Kirklin","year":"2015","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref78-bib78","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.healun.2012.05.004","article-title":"Continuous-flow devices and percutaneous site infections: clinical outcomes","volume":"31","author":"Goldstein","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref79-bib79","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.healun.2017.01.478","article-title":"Clinical outcomes of adults with elevated body mass index with destination therapy: an analysis of INTERMACS registry","volume":"36","author":"Jaiswal","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref80-bib80","doi-asserted-by":"crossref","first-page":"e016203","DOI":"10.1161\/JAHA.119.016203","article-title":"Dynamic forecasts of survival for patients living with destination left ventricular assist devices: insights from INTERMACS","volume":"9","author":"Michelis","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"key2024082718460900_ref81-bib81","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/eci.12562","article-title":"Outcome of conservative management vs. assist device implantation in patients with advanced refractory heart failure","volume":"46","author":"Adlbrecht","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"key2024082718460900_ref82-bib82","first-page":"51","article-title":"Left ventricular assist devices as destination therapy","volume":"65","author":"Medressova","year":"2019","journal-title":"ASAIO J"},{"key":"key2024082718460900_ref83-bib83","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.acvd.2020.05.018","article-title":"Septuagenarian population has similar survival and outcomes to younger patients after left ventricular assist device implantation","volume":"113","author":"Galand","year":"2020","journal-title":"Arch Cardiovasc Dis"},{"key":"key2024082718460900_ref84-bib84","doi-asserted-by":"crossref","first-page":"S387","DOI":"10.1016\/j.healun.2021.01.1087","article-title":"Absolute risk of death is lower in left ventricular assist device patients with good anticoagulation control","volume":"40","author":"Janssen","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref85-bib85","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/MAT.0000000000000916","article-title":"Obesity is associated with driveline infection of left ventricular assist devices","volume":"65","author":"Akay","year":"2019","journal-title":"ASAIO J"},{"key":"key2024082718460900_ref86-bib86","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.healun.2016.01.1222","article-title":"Age and gender differences and factors related to change in health-related quality of life from before to 6 months after left ventricular assist device implantation: findings from Interagency Registry for Mechanically Assisted Circulatory Support","volume":"35","author":"Grady","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref87-bib87","volume-title":"STS INTERMACS Database","author":"The Society of Thoracic Surgeons","year":"2022"},{"key":"key2024082718460900_ref90-bib90","volume-title":"Health Technology Assessment (HTA) No. 264","author":"Neyt","year":"2016"},{"key":"key2024082718460900_ref91-bib91","first-page":"1","article-title":"Left ventricular assist devices for destination therapy: a Health Technology Assessment","volume":"16","author":"Health Quality Ontario","year":"2016","journal-title":"Ont Health Technol Assess Ser"},{"key":"key2024082718460900_ref92-bib92","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/ejcts\/ezy285","article-title":"A network meta-analysis of randomized trials and observational studies on left ventricular assist devices in adult patients with end-stage heart failure","volume":"55","author":"Cavarretta","year":"2019","journal-title":"Eur J Cardiothorac Surg"},{"key":"key2024082718460900_ref93-bib93","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s40258-018-0439-x","article-title":"A systematic review of cost-effectiveness analyses of left ventricular assist devices: issues and challenges","volume":"17","author":"Schmier","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"key":"key2024082718460900_ref94-bib94","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198529446.001.0001","volume-title":"Methods for the Economic Evaluation of Health Care Programmes","author":"Drummond","year":"2005"},{"key":"key2024082718460900_ref96-bib96","volume-title":"Developing the Research Question","author":"Booth","year":"2003"},{"key":"key2024082718460900_ref97-bib97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: consensus on Health Economic Criteria","volume":"21","author":"Evers","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024082718460900_ref98-bib98","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol Assess"},{"key":"key2024082718460900_ref99-bib99","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"key2024082718460900_ref100-bib100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1179\/2295333714Y.0000000017","article-title":"Cost of 1-year left ventricular assist device destination therapy in chronic heart failure: a comparison with heart transplantation","volume":"69","author":"Droogne","year":"2014","journal-title":"Acta Clin Belg"},{"key":"key2024082718460900_ref101-bib101","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jchf.2016.09.008","article-title":"Cost-effectiveness of left ventricular assist devices in ambulatory patients with advanced heart failure","volume":"5","author":"Baras Shreibati","year":"2017","journal-title":"JACC Heart Fail"},{"key":"key2024082718460900_ref102-bib102","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1017\/S0266462313000238","article-title":"Cost-effectiveness of continuous-flow left ventricular assist devices","volume":"29","author":"Neyt","year":"2013","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024082718460900_ref103-bib103","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jtcvs.2009.02.016","article-title":"Left ventricular assist device as destination therapy: application of the payment-by-results approach for the device reimbursement","volume":"138","author":"Messori","year":"2009","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key2024082718460900_ref104-bib104","volume-title":"Introduction of Artificial and Support Heart as Destination Therapy for Patients with End-stage Heart Failure","author":"Adang","year":"2006"},{"key":"key2024082718460900_ref106-bib106","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cjca.2017.07.012","article-title":"Economic evaluation of left ventricular assist devices for patients with end stage heart failure who are ineligible for cardiac transplantation","volume":"33","author":"Chew","year":"2017","journal-title":"Can J Cardiol"},{"key":"key2024082718460900_ref107-bib107","first-page":"656","article-title":"Institutional cost comparison between heart transplants and left ventricular assist device implantations","volume":"14","author":"Chimanji","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"key2024082718460900_ref108-bib108","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1017\/S0266462307070353","article-title":"Clinical and cost-effectiveness of left ventricular assist devices as destination therapy for people with end-stage heart failure: a systematic review and economic evaluation","volume":"23","author":"Clegg","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024082718460900_ref109-bib109","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1017\/S0266462307070365","article-title":"Modeling payback from research into the efficacy of left-ventricular assist devices as destination therapy","volume":"23","author":"Girling","year":"2007","journal-title":"Int J Technol Assess Health Care"},{"key":"key2024082718460900_ref110-bib110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.healun.2021.11.014","article-title":"A clinical and cost-effectiveness analysis of the HeartMate 3 left ventricular assist device for transplant-ineligible patients: a United Kingdom perspective","volume":"41","author":"Lim","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref111-bib111","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCHEARTFAILURE.113.000807","article-title":"Comparative survival and cost-effectiveness of advanced therapies for end-stage heart failure","volume":"7","author":"Long","year":"2014","journal-title":"Circ Heart Fail"},{"key":"key2024082718460900_ref112-bib112","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/CIRCULATIONAHA.118.035722","article-title":"Healthcare resource use and cost implications in the MOMENTUM 3 long-term outcome study","volume":"138","author":"Mehra","year":"2018","journal-title":"Circulation"},{"key":"key2024082718460900_ref113-bib113","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/01.sla.0000090447.73384.ad","article-title":"Left ventricular assist devices as permanent heart failure therapy: the price of progress","volume":"238","author":"Oz","year":"2003","journal-title":"Ann Surg"},{"key":"key2024082718460900_ref114-bib114","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCHEARTFAILURE.111.962951","article-title":"Cost-effectiveness analysis of continuous-flow left ventricular assist devices as destination therapy","volume":"5","author":"Rogers","year":"2012","journal-title":"Circ Heart Fail"},{"key":"key2024082718460900_ref115-bib115","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.healun.2019.01.312","article-title":"Cost-effectiveness of a small intrapericardial centrifugal LVAD versus medical management and heart transplantation","volume":"38","author":"Silvestry","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref116-bib116","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1002\/ehf2.13401","article-title":"Cost-effectiveness of left ventricular assist devices as destination therapy in the United Kingdom","volume":"8","author":"Schueler","year":"2021","journal-title":"ESC Heart Fail"},{"key":"key2024082718460900_ref117-bib117","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1540-8191.2011.01292.x","article-title":"Temporal changes in hospital costs for left ventricular assist device implantation","volume":"26","author":"Slaughter","year":"2011","journal-title":"J Card Surg"},{"key":"key2024082718460900_ref118-bib118","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0003-4975(97)01000-X","article-title":"Quality of life with an implanted left ventricular assist device","volume":"64","author":"Moskowitz","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"key2024082718460900_ref119-bib119","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.healun.2006.09.011","article-title":"Cost-effectiveness of ventricular assist device use in the United Kingdom: results from the evaluation of ventricular assist device programme in the UK (EVAD-UK)","volume":"25","author":"Sharples","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref120-bib120","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/eurheartj\/ehi857","article-title":"Clinical and cost-effectiveness of left ventricular assist devices as a bridge to heart transplantation for people with end-stage heart failure: a systematic review and economic evaluation","volume":"27","author":"Clegg","year":"2007","journal-title":"Eur Heart J"},{"key":"key2024082718460900_ref121-bib121","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jval.2013.02.002","article-title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) \u2013 explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","volume":"16","author":"Husereau","year":"2013","journal-title":"Value Health"},{"key":"key2024082718460900_ref122-bib122","volume-title":"NICE Health Technology Evaluations: The Manual","author":"National Institute for Health and Care Excellence","year":"2022"},{"key":"key2024082718460900_ref123-bib123","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision Modelling for Health Economic Evaluation","author":"Briggs","year":"2006"},{"key":"key2024082718460900_ref124-bib124","volume-title":"National Life Tables \u2013 Life Expectancy in the UK: 2018 to 2020","author":"Office for National Statistics","year":"2021"},{"key":"key2024082718460900_ref125-bib125","volume-title":"Cost-effectiveness of Interventions for Smoking Cessation","author":"Flack","year":"2008"},{"key":"key2024082718460900_ref126-bib126","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ejhf.2211","article-title":"Primary results of long-term outcomes in the MOMENTUM 3 pivotal trial and continued access protocol study phase: a study of 2200 HeartMate 3 left ventricular assist device implants","volume":"23","author":"Mehra","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"key2024082718460900_ref127-bib127","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.healun.2018.09.021","article-title":"Outcomes with ambulatory advanced heart failure from the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) Registry","volume":"38","author":"Ambardekar","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref128-bib128","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/STROKEAHA.117.017866","article-title":"Evolution of the modified Rankin Scale and its use in future stroke trials","volume":"48","author":"Broderick","year":"2017","journal-title":"Stroke"},{"key":"key2024082718460900_ref129-bib129","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.healun.2020.04.006","article-title":"Quantifying the impact from stroke during support with continuous flow ventricular assist devices: an STS INTERMACS analysis","volume":"39","author":"Kirklin","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref130-bib130","first-page":"S52","article-title":"Right heart failure post left ventricular assist device implantation","volume":"6","author":"Argiriou","year":"2014","journal-title":"J Thorac Dis"},{"key":"key2024082718460900_ref131-bib131","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.jtcvs.2009.11.020","article-title":"Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes","volume":"139","author":"Kormos","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"key2024082718460900_ref132-bib132","first-page":"888","article-title":"Right heart failure and \u201cfailure to thrive\u201d after left ventricular assist device: clinical predictors and outcomes","volume":"30","author":"Baumwol","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref133-bib133","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jjcc.2021.12.009","article-title":"Late-onset right ventricular failure after continuous-flow left ventricular assist device implantation: case presentation and review of the literature","volume":"80","author":"Hatano","year":"2022","journal-title":"J Cardiol"},{"key":"key2024082718460900_ref134-bib134","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.21037\/jtd-20-2228","article-title":"Right ventricular failure after left ventricular assist device implantation: a review of the literature","volume":"13","author":"Lo Coco","year":"2021","journal-title":"J Thorac Dis"},{"key":"key2024082718460900_ref135-bib135","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1161\/STROKEAHA.114.008547","article-title":"Adopting a patient-centered approach to primary outcome analysis of acute stroke trials using a utility-weighted modified Rankin Scale","volume":"46","author":"Chaisinanunkul","year":"2015","journal-title":"Stroke"},{"key":"key2024082718460900_ref136-bib136","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-154-1-201101040-00289","article-title":"Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation","volume":"154","author":"Freeman","year":"2011","journal-title":"Ann Intern Med"},{"key":"key2024082718460900_ref137-bib137","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.healun.2017.07.005","article-title":"Eighth annual INTERMACS report: special focus on framing the impact of adverse events","volume":"36","author":"Kirklin","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref138-bib138","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1056\/NEJMoa0706719","article-title":"Quality of life with defibrillator therapy or amiodarone in heart failure","volume":"359","author":"Mark","year":"2008","journal-title":"N Engl J Med"},{"key":"key2024082718460900_ref139-bib139","doi-asserted-by":"crossref","first-page":"186","DOI":"10.21037\/acs-2021-cfmcs-35","article-title":"Contemporary outcomes of continuous-flow left ventricular assist devices \u2013 a systematic review","volume":"10","author":"McNamara","year":"2021","journal-title":"Ann Cardiothorac Surg"},{"key":"key2024082718460900_ref140-bib140","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/0962280211419832","article-title":"Probabilistic sensitivity analysis in health economics","volume":"24","author":"Baio","year":"2015","journal-title":"Stat Methods Med Res"},{"key":"key2024082718460900_ref141-bib141","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s40273-017-0584-3","article-title":"A new approach for sampling ordered parameters in probabilistic sensitivity analysis","volume":"36","author":"Ren","year":"2018","journal-title":"Pharmacoeconomics"},{"key":"key2024082718460900_ref142-bib142","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/hec.903","article-title":"Cost-effectiveness acceptability curves \u2013 facts, fallacies and frequently asked questions","volume":"13","author":"Fenwick","year":"2004","journal-title":"Health Econ"},{"key":"key2024082718460900_ref143-bib143","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/0272989X18797948","article-title":"Value of information choices that influence estimates: a systematic review of prevailing considerations","volume":"38","author":"Koffijberg","year":"2018","journal-title":"Med Decis Making"},{"key":"key2024082718460900_ref144-bib144","volume-title":"Carrying NICE Over the Threshold","author":"Dillon","year":"2015"},{"key":"key2024082718460900_ref145-bib145","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.healun.2013.10.017","article-title":"Overall quality of life improves to similar levels after mechanical circulatory support regardless of severity of heart failure before implantation","volume":"33","author":"Grady","year":"2014","journal-title":"J Heart Lung Transplant"},{"key":"key2024082718460900_ref146-bib146","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jval.2022.02.004","article-title":"Considering severity in Health Technology Assessment: can we do better?","volume":"25","author":"Skedgel","year":"2022","journal-title":"Value Health"},{"key":"key2024082718460900_ref147-bib147","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N Engl J Med"},{"key":"key2024082718460900_ref148-bib148","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.2022.16197","article-title":"Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial","volume":"328","author":"Mehra","year":"2022","journal-title":"JAMA"},{"key":"key2024082718460900_ref149-bib149","author":"Karason","year":"2014"},{"key":"key2024082718460900_ref151-bib151","volume-title":"About NICOR","author":"National Institute for Cardiovascular Outcomes Research","year":"2019"},{"key":"key2024082718460900_ref152-bib152","volume-title":"The Myocardial Ischaemia National Audit Project (MINAP)","author":"National Institute for Cardiovascular Outcomes Research","year":"2019"},{"key":"key2024082718460900_ref153-bib153","volume-title":"About EUROMACS","author":"European Registry for Patients with Mechanical Circulatory Support","year":"2019"},{"key":"key2024082718460900_ref154-bib154","volume-title":"The STS Intermacs Database","author":"University of Alabama at Birmingham","year":"2018"},{"key":"key2024082718460900_ref155-bib155","volume-title":"The International Society for Heart and Lung Transplantation Registry for Mechanically Assisted Circulatory Support (IMACS)","author":"The International Society for Heart and Lung Transplantation","year":"2019"},{"key":"key2024082718460900_ref156-bib156","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijcard.2013.12.015","article-title":"Cost-effectiveness of left ventricular assist devices (LVADs) for patients with advanced heart failure: analysis of the British NHS bridge to transplant (BTT) program","volume":"171","author":"Clarke","year":"2014","journal-title":"Int J Cardiol"},{"key":"key2024082718460900_ref157-bib157","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamacardio.2019.5323","article-title":"Association of clinical outcomes with left ventricular assist device use by bridge to transplant or destination therapy intent: the Multicenter Study of MagLev Technology in patients undergoing mechanical circulatory support therapy with HeartMate 3 (MOMENTUM 3) randomized clinical trial","volume":"5","author":"Goldstein","year":"2020","journal-title":"JAMA Cardiol"},{"key":"key2024082718460900_ref158-bib158","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.hrtlng.2007.10.007","article-title":"Predictors of rehospitalization time during the first year after heart transplant","volume":"37","author":"Jalowiec","year":"2008","journal-title":"Heart Lung"},{"key":"key2024082718460900_ref159-bib159","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jchf.2017.02.016","article-title":"ROADMAP Study Investigators. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP study 2-year results","volume":"5","author":"Starling","year":"2017","journal-title":"JACC Heart Fail"},{"key":"key2024082718460900_ref160-bib160","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ahj.2019.04.021","article-title":"Risk factors and prognostic impact of left ventricular assist device-associated infections","volume":"214","author":"Tattevin","year":"2019","journal-title":"Am Heart J"},{"key":"key2024082718460900_ref161-bib161","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1093\/eurheartj\/ehad583","article-title":"Economic burden of cardiovascular diseases in the European Union: a population-based cost study","volume":"44","author":"Luengo-Fernandez","year":"2023","journal-title":"Eur Heart J"},{"key":"key2024082718460900_ref162-bib162","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ehjacc\/zuaa035","article-title":"Influence of age and shock severity on short-term survival in patients with cardiogenic shock","volume":"10","author":"Jentzer","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2045758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/publications\/MLFA4009\/MLFA4009.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2045758","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T13:23:57Z","timestamp":1724765037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/MLFA4009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":152,"alternative-id":["10.3310\/MLFA4009"],"URL":"https:\/\/doi.org\/10.3310\/mlfa4009","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"02-2020","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"01-2023","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"08-2023","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}